These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36769555)

  • 21. [Antibodies to ganglioside GM1 and Campylobacter jejuni in patients with Guillain-Barré syndrome].
    Basta I; Suturkova L; Vujić A; Aleksić S; Poceva A; Paskoska A; Milenikova K; Trikić R; Apostolski S
    Srp Arh Celok Lek; 2005; 133(3-4):123-8. PubMed ID: 16206698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
    Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
    Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome following chickenpox: a case series.
    Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
    Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.
    Visser LH; van der Meché FG; Meulstee J; Rothbarth PP; Jacobs BC; Schmitz PI; van Doorn PA
    Neurology; 1996 Sep; 47(3):668-73. PubMed ID: 8797462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus Infection and Guillain-Barré Syndrome: The First Case-Control Study in Iran.
    Mamishi S; Ashrafi MR; Mohammadi M; Zamani G; Pourakbari B; Mahmoudi S; Aziz-Ahari S
    Iran J Child Neurol; 2021; 15(4):35-41. PubMed ID: 34782840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guillain-Barré syndrome in HIV-infected patients at Bobo-Dioulasso Hospital (Burkina Faso)].
    Millogo A; Sawadogo A; Lankoandé D; Sawadogo AB
    Rev Neurol (Paris); 2004 May; 160(5 Pt 1):559-62. PubMed ID: 15269674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult.
    Cresswell F; Eadie J; Longley N; Macallan D
    Int J Infect Dis; 2010 Feb; 14(2):e161-3. PubMed ID: 19502090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome.
    Hadden RD; Karch H; Hartung HP; Zielasek J; Weissbrich B; Schubert J; Weishaupt A; Cornblath DR; Swan AV; Hughes RA; Toyka KV;
    Neurology; 2001 Mar; 56(6):758-65. PubMed ID: 11274311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
    I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
    Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AntiGQ1b antibody positive with MFS/GBS overlapped syndrome with diplopia and hemiplegia onset: Case report and retrospective analysis.
    Zhao M; Gu Y; Zhao J; Li N
    Medicine (Baltimore); 2022 Sep; 101(37):e30584. PubMed ID: 36123885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
    Das S; Khan RK; Alam SM; Chowdhury NH; Das P
    Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes.
    Uncini A; Manzoli C; Notturno F; Capasso M
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1157-63. PubMed ID: 20870864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Zika Virus and Guillain-Barré Syndrome].
    Koike H
    Brain Nerve; 2018 Feb; 70(2):113-120. PubMed ID: 29433112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
    J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HIV-associated neuropathies].
    Hahn K; Husstedt IW;
    Nervenarzt; 2010 Apr; 81(4):409-17. PubMed ID: 20195565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
    Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
    Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.
    Kaida K; Ariga T; Yu RK
    Glycobiology; 2009 Jul; 19(7):676-92. PubMed ID: 19240270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in management of Guillain-Barré syndrome.
    Doets AY; Jacobs BC; van Doorn PA
    Curr Opin Neurol; 2018 Oct; 31(5):541-550. PubMed ID: 30074496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.